# FDA Inspection 783745 - Aurobindo Pharma USA Inc - May 30, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-usa-inc/2fe29140-07b2-439a-8b7e-630234c4b31e
Source feed: FDA_Inspections

> FDA Inspection 783745 for Aurobindo Pharma USA Inc on May 30, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 783745
- Company Name: Aurobindo Pharma USA Inc
- Inspection Date: 2012-05-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1238442 - 2024-05-15](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-usa-inc/653906f9-7952-4bff-9baa-c6b093dcc401)
- [FDA Inspection 908515 - 2014-12-12](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-usa-inc/8aafb05c-4cf0-4b3b-9b91-e66abfff7110)
- [FDA Inspection 908515 - 2014-12-12](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-usa-inc/f5f64249-fa72-42e3-b88d-44a5db92235c)
- [FDA Inspection 736360 - 2011-07-29](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-usa-inc/36c27227-4edf-4744-8d83-14dfbf343604)
- [FDA Inspection 736360 - 2011-07-29](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-usa-inc/bacfcc10-9940-4b19-9084-4bb60639c9f3)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-usa-inc/a8dbf5ca-1af1-432a-85b6-5a0c7499eaa5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c